QQQ   267.51 (+0.24%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.24%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.24%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.24%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
Log in
ASX:ADO

Anteo Diagnostics Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$0.02
MA: A$0.02
A$0.02
52-Week Range N/A
Volume1.43 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Anteo Diagnostics Limited engages in developing, commercializing, manufacturing, and distributing products for the life sciences research, in-vitro diagnostics, energy, and medical device markets primarily in Australia. Its principal technology products include AnteoCoat, which is applicable to the energy sector in lithium-ion batteries; AnteoBind that is applicable to point of care, in vitro, and life science diagnostic sectors; and AnteoRelease, which is applicable in the medical technology sector comprising implants for infectious diseases. The company also manufactures and sells in vitro diagnostic tests. Anteo Diagnostics Limited has a collaboration with Sona Nanotech Inc. to co-develop new products that have the potential to speed up the development and improve the performance of lateral flow immunoassays. The company was formerly known as Biolayer Corporation Limited and changed its name to Anteo Diagnostics Limited in November 2008. Anteo Diagnostics Limited is based in Eight Mile Plains, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.54 out of 5 stars


Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 7 3219 0085

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.27 million
Book ValueA$0.00 per share

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive ADO News and Ratings via Email

Sign-up to receive the latest news and ratings for ADO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Anteo Diagnostics (ASX:ADO) Frequently Asked Questions

How were Anteo Diagnostics' earnings last quarter?

Anteo Diagnostics Ltd (ASX:ADO) posted its quarterly earnings results on Wednesday, February, 27th. The company reported $0.00 earnings per share for the quarter.
View Anteo Diagnostics' earnings history
.

Who are some of Anteo Diagnostics' key competitors?

What other stocks do shareholders of Anteo Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Anteo Diagnostics investors own include Mesoblast (MSB) and Evolution Mining (EVN).

Who are Anteo Diagnostics' key executives?

Anteo Diagnostics' management team includes the following people:
  • Mr. Christopher Parker, Chief Exec. Officer
  • Dr. N. Joe Maeji Ph.D., Founder & Chief Scientific Officer
  • Mr. Duncan Patrick Cornish ACA, CFO & Company Sec. (Age 52)
  • Mr. Julien Francis McInally B.Bus, MBA, CPA, Company Sec. & CFO (Age 47)
  • Dr. Charlie Huang, Head of R&D

What is Anteo Diagnostics' stock symbol?

Anteo Diagnostics trades on the ASX under the ticker symbol "ADO."

How big of a company is Anteo Diagnostics?

Anteo Diagnostics has a market capitalization of $0.00 and generates $1.27 million in revenue each year.

What is Anteo Diagnostics' official website?

The official website for Anteo Diagnostics is www.anteodx.com.

How can I contact Anteo Diagnostics?

The company can be reached via phone at 61 7 3219 0085.

This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.